Free. Unsubscribe any time.
Zai Lab Ltd (ZLAB)
Zai Lab Ltd filed 31 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 54 transactions and 1,114,871 shares. 31 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-21, came 8 days after the one before it (2026-08-13) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 260 shares, 8,246 fewer than the 8,506 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 31 filings on file run from 2025-03-04 to 2026-08-21, and state 11 plan adoption dates, from 2024-05-29 to 2025-12-16.
Trades in Zai Lab Ltd 54
- Du Ying — 2025-02-28 · S · 2,857 shares
- Du Ying — 2025-02-28 · S · 46,943 shares
- Du Ying — 2025-02-28 · S · 200 shares
- Edmondson Frazor Titus III — 2025-02-28 · S · 14,544 shares
- Lis William — 2025-02-28 · S · 15,000 shares
- Du Ying — 2025-03-03 · S · 23,110 shares
- Du Ying — 2025-03-03 · S · 24,280 shares
- Du Ying — 2025-03-03 · S · 2,610 shares
- Du Ying — 2025-03-04 · S · 6,665 shares
- Du Ying — 2025-03-04 · S · 37,752 shares
- Du Ying — 2025-03-04 · S · 5,583 shares
- Du Ying — 2025-03-05 · S · 21,093 shares
Adoption dates in Zai Lab Ltd 11
- 2024-05-29 — stated in 1 filing
- 2024-11-20 — stated in 7 filings
- 2024-11-22 — stated in 3 filings
- 2025-03-03 — stated in 3 filings
- 2025-03-04 — stated in 1 filing
- 2025-09-10 — stated in 2 filings
- 2025-09-12 — stated in 3 filings
- 2025-11-11 — stated in 6 filings
- 2025-11-15 — stated in 1 filing
- 2025-12-09 — stated in 2 filings
- 2025-12-16 — stated in 2 filings
Results prints in Zai Lab Ltd 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades before a print in Zai Lab Ltd 0
- 36 days before the 2026-08-06 print — 2026-07-01 · P · GAYNOR RICHARD · 1,736 shares
- 45 days before the 2026-08-06 print — 2026-06-22 · S · Lis William · 7,040 shares
- 48 days before the 2025-08-07 print — 2025-06-20 · S · Lis William · 13,814 shares
- 51 days before the 2026-05-07 print — 2026-03-17 · P · GAYNOR RICHARD · 1,731 shares
- 52 days before the 2025-05-08 print — 2025-03-17 · S · Amado Rafael · 3,000 shares
- 57 days before the 2026-05-07 print — 2026-03-11 · S · Du Ying · 1,067 shares
- 59 days before the 2026-05-07 print — 2026-03-09 · S · Du Ying · 50,000 shares
- 62 days before the 2026-05-07 print — 2026-03-06 · S · Du Ying · 50,000 shares
- 63 days before the 2026-05-07 print — 2026-03-05 · S · Du Ying · 50,000 shares
- 63 days before the 2026-05-07 print — 2026-03-05 · S · Edmondson Frazor Titus III · 15,569 shares
- 64 days before the 2025-05-08 print — 2025-03-05 · S · Du Ying · 21,093 shares
- 64 days before the 2025-05-08 print — 2025-03-05 · S · Du Ying · 25,296 shares
Interval to Zai Lab Ltd’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 36shortest, days
- 3no later print
Adoption dates Zai Lab Ltd states
- 2024-05-29 in 1 filing
- 2024-11-20 in 7 filings
- 2024-11-22 in 3 filings
- 2025-03-03 in 3 filings
- 2025-03-04 in 1 filing
- 2025-09-10 in 2 filings
- 2025-09-12 in 3 filings
- 2025-11-11 in 6 filings
- 2025-11-15 in 1 filing
- 2025-12-09 in 2 filings
- 2025-12-16 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on November 20, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.